
AstraZeneca PLC AZN
$ 92.87
1.28%
Annual report 2024
added 01-24-2026
AstraZeneca PLC Historical Prices 2011-2026 | AZN
Annual Historical Prices AstraZeneca PLC
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.2 | 65.7 | 68.3 | 57.3 | 48.4 | 45.3 | 32.9 | 30.4 | 22.5 | 25.4 | 25.4 | 21.8 | 15.6 | 14.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 74.2 | 14.7 | 39.1 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
1.56 | $ 2.62 | 28.82 % | $ 147 M | ||
|
GlaxoSmithKline plc
GSK
|
40.1 | $ 48.98 | 0.68 % | $ 173 B | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.51 | 7.34 % | $ 8.45 B | ||
|
Grifols, S.A.
GRFS
|
6.65 | $ 9.25 | 1.49 % | $ 6.83 B | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
Galapagos NV
GLPG
|
23.8 | $ 34.61 | 0.61 % | $ 2.69 B | ||
|
BioLineRx Ltd.
BLRX
|
2.65 | $ 3.1 | 4.49 % | $ 908 M | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
Zoetis
ZTS
|
165 | $ 123.99 | -0.31 % | $ 56.3 B | ||
|
BioNTech SE
BNTX
|
95.4 | $ 116.27 | -1.86 % | $ 27.2 B | ||
|
Ascendis Pharma A/S
ASND
|
153 | $ 235.41 | 2.95 % | $ 5 B | ||
|
Burford Capital Limited
BUR
|
10.6 | $ 9.74 | -1.37 % | $ 1.55 B | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
46.7 | $ 67.49 | -3.02 % | $ 9.03 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 4.51 | 8.41 % | $ 9.81 B | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
27 | $ 25.92 | -0.86 % | $ 1.26 B | ||
|
Amneal Pharmaceuticals
AMRX
|
5.91 | $ 13.49 | -0.66 % | $ 4.17 B | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | ||
|
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
2.51 | $ 2.66 | -1.85 % | $ 16.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | ||
|
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | ||
|
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
133 | $ 171.89 | -1.1 % | $ 25 B |